Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes

OBJECTIVE: To determine variables associated with glycemic and body weight responses when adding exenatide to basal insulin–treated type 2 diabetes. RESEARCH DESIGN AND METHODS: Exploratory subgroup analyses based on baseline A1C, disease duration, and BMI of a 30-week study comparing exenatide twic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rosenstock, Julio, Shenouda, Sylvia K., Bergenstal, Richard M., Buse, John B., Glass, Leonard C., Heilmann, Cory R., Kwan, Anita Y.M., MacConell, Leigh A., Hoogwerf, Byron James
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2012
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3329851/
https://ncbi.nlm.nih.gov/pubmed/22432107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-1434
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak